IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
40.11
-1.66 (-3.97%)
Aug 28, 2026, 4:00 PM EDT - Market closed
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $3.87 billion as of August 28, 2026. Its market cap has increased by 76.63% in one year.
Market Cap
3.87B
Enterprise Value
2.66B
1-Year Change
76.63%
Ranking
Category
Stock Price
$40.11
ChartMarket Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $3.87B, an increase of 1,695.35%. That is a compound annual growth rate of 48.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 3.87B | 27.70% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 4.24B |
| Relay Therapeutics | 4.11B |
| Veradermics | 4.09B |
| Tango Therapeutics | 3.94B |
| Legend Biotech | 3.85B |
| Denali Therapeutics | 3.84B |
| Telix Pharmaceuticals | 3.82B |
| Viking Therapeutics | 3.75B |